| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS42001696 | EBV | ENSG00000077782.23 | protein_coding | FGFR1 | Yes | No | 2260 | A0A0S2Z3Q6 P11362 |
| TVIS10017407 | HBV | ENSG00000077782.23 | protein_coding | FGFR1 | Yes | No | 2260 | A0A0S2Z3Q6 P11362 |
| TVIS30009529 | HIV | ENSG00000077782.23 | protein_coding | FGFR1 | Yes | No | 2260 | A0A0S2Z3Q6 P11362 |
| TVIS30009530 | HIV | ENSG00000077782.23 | protein_coding | FGFR1 | Yes | No | 2260 | A0A0S2Z3Q6 P11362 |
| TVIS30068820 | HIV | ENSG00000077782.23 | protein_coding | FGFR1 | Yes | No | 2260 | A0A0S2Z3Q6 P11362 |
| TVIS30068821 | HIV | ENSG00000077782.23 | protein_coding | FGFR1 | Yes | No | 2260 | A0A0S2Z3Q6 P11362 |
| TVIS30068822 | HIV | ENSG00000077782.23 | protein_coding | FGFR1 | Yes | No | 2260 | A0A0S2Z3Q6 P11362 |
| TVIS30068823 | HIV | ENSG00000077782.23 | protein_coding | FGFR1 | Yes | No | 2260 | A0A0S2Z3Q6 P11362 |
| TVIS30068824 | HIV | ENSG00000077782.23 | protein_coding | FGFR1 | Yes | No | 2260 | A0A0S2Z3Q6 P11362 |
| TVIS20031100 | HPV | ENSG00000077782.23 | protein_coding | FGFR1 | Yes | No | 2260 | A0A0S2Z3Q6 P11362 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | FGFR1 |
|---|---|
| DrugBank ID | DB08901 |
| Drug Name | Ponatinib |
| Target ID | BE0002131 |
| UniProt ID | P11362 |
| Regulation Type | inhibitor |
| PubMed IDs | 23563700; 23468082 |
| Citations | Ren M, Hong M, Liu G, Wang H, Patel V, Biddinger P, Silva J, Cowell J, Hao Z: Novel FGFR inhibitor ponatinib suppresses the growth of non-small cell lung cancer cells overexpressing FGFR1. Oncol Rep. 2013 Jun;29(6):2181-90. doi: 10.3892/or.2013.2386. Epub 2013 Apr 4.@@Gozgit JM, Squillace RM, Wongchenko MJ, Miller D, Wardwell S, Mohemmad Q, Narasimhan NI, Wang F, Clackson T, Rivera VM: Combined targeting of FGFR2 and mTOR by ponatinib and ridaforolimus results in synergistic antitumor activity in FGFR2 mutant endometrial cancer models. Cancer Chemother Pharmacol. 2013 May;71(5):1315-23. doi: 10.1007/s00280-013-2131-z. Epub 2013 Mar 7. |
| Groups | Approved; Investigational |
| Direct Classification | Benzanilides |
| SMILES | CN1CCN(CC2=CC=C(NC(=O)C3=CC(C#CC4=CN=C5C=CC=NN45)=C(C)C=C3)C=C2C(F)(F)F)CC1 |
| Pathways | Ponatinib Inhibition of BCR-ABL |
| PharmGKB | PA165980594 |
| ChEMBL | CHEMBL1171837 |
